Pardes Biosciences, Inc. - PRDS
-
Commons
$1.88
+1.35%PRDS Vol: 4.0M
SPAC Stats
Market Cap: 116.6M
Average Volume: 97.7K
52W Range: $0.75 - $5.07
Weekly %: +2.72%
Monthly %: -2.07%
Inst Owners: 0
Info
🎯Price Targets
Rating
Analyst Firm
Price Target
1/18/22
Buy - $25.0
03/15/22
Outperform - $18.0
🕵Stocktwit Mentions
tickeron posted at 2023-06-21T12:05:08Z
What is the difference between $ABUS and $PRDS? Learn it. #ArbutusBiopharma https://srnk.us/go/4745316
MaryLamote1 posted at 2023-06-20T23:55:25Z
$PRDS https://tradingjunkie.space/?s=PRDS&ref=43302
tickeron posted at 2023-06-17T18:04:06Z
$AADI vs. $PRDS: what is the best stock to add to your portfolio? #AadiBioscience https://srnk.us/go/4735907
valorallure posted at 2023-06-10T13:57:01Z
$PRDS I value shares at $2.34. This takes into account cash burn for next year and a half. $10 million in cash burn next quarter and $1 million in cash burn a quarter going forward after that. I'd hope Foresite would at least offer Net cash value which at these prices would be a 25% return. I think a price above net cash would be fair due to $PRDS patent claim on Pfizer's Paxlovid. No reverse merger which I find value destructive is great news because Foresight won't vote yes on a reverse merger and they control 25% of company. Great low risk high reward value play here with excellent catalyst in place.
valorallure posted at 2023-06-09T06:28:55Z
$PRDS https://twitter.com/PunditPatent/status/1483451882567839750
BidaskBot posted at 2023-06-07T00:20:17Z
PardesBiosciences $PRDS BidaskScore is Downgraded to Held https://bidaskclub.com/news/company/2023-06-05/PRDS
valorallure posted at 2023-06-06T22:20:31Z
$PRDS Curious what the buyout offer price is from Foresite. Foresite said they wouldn't vote for any other deal and they own over 25% of shares so the two companies must be negotiating at the table.
Last10K posted at 2023-06-05T20:07:35Z
$PRDS just filed with the SEC a Event for Officers, a Vote of Security Holders and a Financial Exhibit https://last10k.com/sec-filings/prds/0000950170-23-026348.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=prds
EarningsInsider posted at 2023-06-05T20:06:41Z
Pardes Biosciences, Inc. Files SEC Form 8-K $PRDS https://www.marketbeat.com/stocks/NASDAQ/PRDS/sec-filings/
Quantisnow posted at 2023-06-05T20:04:07Z
$PRDS 📜 Pardes Biosciences Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits https://quantisnow.com/i/4602961?utm_source=stocktwits 45 seconds delayed.
risenhoover posted at 2023-06-05T20:03:35Z
$PRDS / Pardes Biosciences files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 1, 2023 PARDES BIOSCIENCES, https://fintel.io/sf/us/prds?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing
macroaxis posted at 2023-06-04T11:05:09Z
$PRDS - Acquisition by Auerbach Mark of 37500 shares of Pardes Biosciences subject to Rule 16b 3 - Pardes Biosciences https://www.macroaxis.com/invest/story/PRDS/27596425/Acquisition-by-Auerbach-Mark-of-37500-shares-of-Pardes-Biosciences-subject-to-Rule-16b-3 #insidertrading #stocks #fintechnews
Quantisnow posted at 2023-06-02T20:38:12Z
$PRDS Several insights in the last few minutes: 1. 📜 SEC Form 4 filed by Autor Deborah M. https://quantisnow.com/i/4596751?utm_source=stocktwits 2. 📜 SEC Form 4 filed by Hamill Laura https://quantisnow.com/i/4596811?utm_source=stocktwits 3. 📜 SEC Form 4 filed by Lobell J Jay https://quantisnow.com/i/4596837?utm_source=stocktwits 4. 📜 SEC Form 4 filed by Lopatin Uri A https://quantisnow.com/i/4596867?utm_source=stocktwits 5. 📜 SEC Form 4 filed by Pottage John C Jr https://quantisnow.com/i/4596929?utm_source=stocktwits 6. 📜 SEC Form 4 filed by Smaldone Alsup Laurie https://quantisnow.com/i/4596947?utm_source=stocktwits 7. 📜 SEC Form 4 filed by Tananbaum James B. https://quantisnow.com/i/4596985?utm_source=stocktwits 8. 📜 SEC Form 4 filed by Varney Michael David https://quantisnow.com/i/4597001?utm_source=stocktwits #healthcare
Quantisnow posted at 2023-06-02T20:06:00Z
$PRDS 📜 SEC Form 4 filed by Auerbach Mark https://quantisnow.com/i/4596737?utm_source=stocktwits 45 seconds delayed.
risenhoover posted at 2023-06-02T00:08:36Z
$PRDS PRDS / Pardes Biosciences Inc Price Target Updated https://fintel.io/sfo/us/prds?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget
BidaskBot posted at 2023-05-29T22:10:22Z
PardesBiosciences $PRDS BidaskScore is Increased to Bought https://bidaskclub.com/news/company/2023-05-23/PRDS
tickeron posted at 2023-05-26T20:11:47Z
What is the difference between $AADI and $PRDS? Learn it. #AadiBioscience https://srnk.us/go/4679732
ChartMill posted at 2023-05-25T00:46:00Z
$PRDS and $INM are showing a squeeze play pattern today. They could be ready for breakout. https://www.chartmill.com/stock/stock-screener?sid=12&f=sqds,v1_50b300,sl_ti_105_X,exch_us&v=3&timeframe=DAILY&type=CANDLES&months=0.05&width=400&cl=F&o1=0&o2=57&op1=14&op2=20,1.5,10&utm_source=stocktwits&utm_medium=screener&utm_content=Stock_Screener:_Momentum_Squeeze_Play_Setups&utm_campaign=social_tracking
ChartMill posted at 2023-05-22T09:13:00Z
Based on estimates for the next 5 years, $PRDS will show a very strong growth in EPS: 51.60% on average per year.. https://www.chartmill.com/stock/quote/PRDS/technical-analysis?key=b990b948-35f5-4ded-8ac0-012ea975650b&utm_source=stocktwits&utm_medium=TA&utm_content=PRDS&utm_campaign=social_tracking
Last10K posted at 2023-05-18T20:19:44Z
$PRDS just filed with the SEC a Event for Officers and a Financial Exhibit https://last10k.com/sec-filings/prds/0000950170-23-023029.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=prds
Quantisnow posted at 2023-05-18T20:12:13Z
$PRDS 📜 Pardes Biosciences Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits https://quantisnow.com/i/4527996?utm_source=stocktwits 45 seconds delayed.
risenhoover posted at 2023-05-18T20:12:00Z
$PRDS / Pardes Biosciences files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 15, 2023 PARDES BIOSCIENCES, https://fintel.io/sf/us/prds?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing
johnnystocks212 posted at 2023-05-18T11:11:07Z
$PRDS https://youtu.be/JebREYe1PeE Let's go $PRDS
BlazingStocks posted at 2023-05-18T02:41:14Z
$PRDS News May 17, 2023 Pardes Biosciences Seeking Strategic Alternatives https://seekingalpha.com/article/4605537-pardes-bioscience-seeking-strategic-alternatives
stockilluminati posted at 2023-05-17T23:49:07Z
$PRDS https://www.stockilluminati.com/prds/news.php - Pardes Biosciences Seeking Strategic Alternatives
flowerchefstocks posted at 2023-05-12T19:09:39Z
$PRDS This is a must read article if you own a former COVID stock. Great analysis of the sector and ideas on who is going to survive. https://www.zerohedge.com/news/2023-05-12/bidens-covid-over-proclamation-extinction-virus-or-lull-next-variant-0
Lectin_Pectin posted at 2023-05-12T17:14:07Z
$AVIR trading like $PRDS at about half of cash. Incredible. These two have options because of cash balance but the best COVID antiviral still appears to be $BIXT. Interesting article here: https://www.zerohedge.com/news/2023-05-12/bidens-covid-over-proclamation-extinction-virus-or-lull-next-variant-0 I'm most bullish on $BIXT since it's an equity play only for management. Hardly any cash salaries!
risenhoover posted at 2023-05-11T00:04:52Z
$PRDS PRDS / FS Development Corp II Price Target Updated https://fintel.io/sfo/us/prds?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget
weight_up posted at 2023-05-10T03:00:46Z
[ BXRX ] 30 RSI + offering closed Almost zero shares to borrow and one of the smallest market caps and float in the whole market! The 4hr chart 8ema and 21 ema are about to cross! This is shaping up to be a very extraordinary play / set up $NOGN $MULN $INDO $PRDS Could heat up soon as well.
ms101 posted at 2023-05-09T10:31:01Z
COVID 2nd gen antiviral pole position leader $ENTA EDP-235 Ph2 failure adds to the short list of the most promising vc backed hyped losers $AVIR $PRDS Now. Full circle. Game changing news for $COCP CDI-988 (after 3 yrs preclinical and rigorously tested with the NIH) P1 otw. https://www.clinicaltrialsarena.com/news/enanta-positive-data-covid-19/